Stéphane Bardet

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial

Martin Schlumberger, Sophie Leboulleux, Bogdan Catargi et al. · The Lancet Diabetes & Endocrinology · 2018 · 158 citations

Cancer Management, Thyroid Disease, Low-risk Thyroid Cancer +6

SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook

Laurence Amar, Jean Philippe Baguet, Stéphane Bardet et al. · Annales d Endocrinologie · 2016 · 73 citations

Adrenal Gland, Aldo-keto Reductase, Medicine +6

¹³¹I‐6β‐Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas

Stéphane Bardet, V. Rohmer, Arnaud Murat et al. · Clinical Endocrinology · 1996 · 71 citations

Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study

Yves Reznik, Hervé Lefèbvre, V. Rohmer et al. · Clinical Endocrinology · 2004 · 69 citations

Shear Wave Elastography in Thyroid Nodules with Indeterminate Cytology: Results of a Prospective Bicentric Study

Stéphane Bardet, Renaud Ciappuccini, Claire Pellot‐Barakat et al. · Thyroid · 2017 · 59 citations